ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 77 | |
4 mg | In stock | $ 130 | |
8 mg | In stock | $ 220 | |
20 mg | In stock | $ 422 | |
40 mg | In stock | $ 662 |
Description | ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS. |
Targets&IC50 | BRD4 (BD2):3 nM (Kd), BRD4 (BD2):4 nM (IC50), BRD3 (BD2):13 nM (IC50), BRDT (BD2):18 nM (IC50), BRD2 (BD2):8 nM (IC50) |
Synonyms | ABBV744, ABBV 744 |
CAS No. | 2138861-99-9 |
Chemical Formula | C28H30FN3O4 |
Molecular Weight | 491.563 |
Solubility | DMSO: 10 mM |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom